Nautilus Biotechnology, Inc. (NAUT) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 0.79 |
| FCF Yield | -46.3% |
| Sector P/E (Technology) | 33.9 |
NAUT overview · NAUT earnings · NAUT KPIs · NAUT investor relations · NAUT ownership · NAUT peers · NAUT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.